Clinical Trial

Safety and Pharmacokinetics of NM6603 in Chinese Patients With Advanced Solid Tumors

Name: Safety and Pharmacokinetics of NM6603 in Chinese Patients With Advanced Solid Tumors — clinical trial record (NCT07292038)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

This study is to assess the MTD and PK of NM6603 in adult patients with advanced solid tumors.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2025-12-05.

Status change: Not Yet Recruiting → Recruiting 2026-01-12

Trial Details

NCT Number	NCT07292038
Lead Sponsor	NucMito Pharmaceuticals Co. Ltd.
Conditions	Cancers
Enrollment	30 participants
Start Date	2025-12-18
Primary Completion	2026-11 (estimated)
Study Completion	2026-11 (estimated)
Updated on ClinicalTrials.gov	2026-01-14